Lynn Morris to Cyclopropanes
                            
                            
                                This is a "connection" page, showing publications Lynn Morris has written about Cyclopropanes.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0,023
         
        
        
     
 
    
        
        - 
            Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2011 Nov 01; 58(3):304-8.
            
            
                Score: 0,023